GRI Bio, Inc. (GRI) — Financial statements
Income statement, balance sheet, and cash flow for GRI Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00↓100.0% | 23 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00↓100.0% | 0.00↓93.0% | 0.06↑14.0% | 0.05↓31.5% | 0.07 | |
| Gross Profit | 0.00↑100.0% | -0.00↑93.0% | -0.06↓14.0% | -0.05↑31.5% | -0.07 | |
| Operating Expenses | ||||||
| R&D Expenses | 7↑81.0% | 4↑16.6% | 3↑1235.5% | 0.24↓95.3% | 5 | |
| General & Administrative Expenses | 5↑17.1% | 4↓45.6% | 8↑305.4% | 2↑145.6% | 0.81 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 0.06 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 5↑15.6% | 4↓44.9% | 8↑315.9% | 2↓51.3% | 4 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 12↑45.5% | 8↓27.4% | 11↑417.6% | 2↓76.2% | 9 | |
| Total Costs & Expenses | 12↑45.4% | 8↓27.7% | 11↑408.6% | 2↓75.8% | 9 | |
| Operating Results | ||||||
| Operating Income | -12↓45.4% | -8↑27.7% | -11↓408.6% | -2↑75.8% | -9 | |
| Depreciation & Amortization | 0.00↑0.0% | 0.00↓93.0% | 0.06↑14.0% | 0.05↓31.5% | 0.07 | |
| EBITDA | -12↓46.0% | -8↑24.7% | -11↓333.5% | -3↑72.7% | -9 | |
| EBIT | -12↓45.9% | -8↑25.1% | -11↓327.3% | -3↑72.4% | -9 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.02↓16.0% | 0.03↑101.2% | -2↓218.8% | -0.65↓3981.3% | -0.02 | |
| Interest Income | 0.02↓16.0% | 0.03 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00↓100.0% | 2↑218.8% | 0.65↑3981.3% | 0.02 | |
| Non-Operating Income | 0.00↑100.0% | -0.03↑93.5% | -0.43↓232.9% | 0.33↑1060.7% | 0.03 | |
| Other Income / Expenses | 0.02↓25.0% | 0.03↑101.7% | -2↓68.7% | -0.98↓2122.7% | -0.04 | |
| Income Before Tax | -12↓45.7% | -8↑37.0% | -13↓305.3% | -3↑65.4% | -9 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -12↓45.7% | -8↑37.0% | -13↓305.3% | -3↑65.4% | -9 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -12↓45.7% | -8↑37.0% | -13↓305.3% | -3↑65.4% | -9 | |
| Bottom-Line Net Income | -12↓18.2% | -10↑22.4% | -13↓305.3% | -3↑65.4% | -9 | |
| EPS (Basic) | -121.80↑92.1% | -1,545.88↑98.9% | -140,450.24↓198.0% | -47,135.48↓1567.2% | -2,827.16 | |
| EPS (Diluted) | -121.80↑92.1% | -1,545.88↑98.9% | -140,450.24↓198.0% | -47,135.48↓1567.2% | -2,827.16 | |
| Weighted Average Shares | 0.10↑1399.6% | 0.01↑314.8% | 0.00↑36.0% | 0.00↓90.0% | 0.01 | |
| Weighted Average Diluted Shares | 0.10↑1399.6% | 0.01↑314.8% | 0.00↑36.0% | 0.00↓90.0% | 0.01 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.